UNSPSC 51282130: Flucloxacillin sodium

This classification denotes a penicillin antibiotic with the molecular structure C19H16CLFN3O5S.NA.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, LMG7C674WJ chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, sodium salt monohydrate (2s(2.alpha.,5.alpha.,6.beta.)), but more commonly known as flucloxacillin sodium, which bears US NIH Compound Identifier 21319.

European Medicines Agency schedules Flucloxacillin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02207MIG. Most nations, for tariff and trade purposes, schedule flucloxacillin sodium under HS 29411090. SMILES: CC1C(C(NO1)C2C(CCCC2CL)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].O.[NA+].

UNSPSC 51282130 Flucloxacillin sodium is a Commodity code that describes a specific beta-lactam antibiotic pharmaceutical product. However, the recent state and local procurement activity tagged to this code shows no relevant solicitations for flucloxacillin sodium itself. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride — distinct antibiotics outside the scope of this code. Seminole County, Florida solicited Naloxone and Safe Drug Deactivation Systems, which are not antimicrobial pharmaceuticals. The code shows little meaningful recent procurement activity aligned with its nominal scope.

The Illinois and Florida opportunities represent different issuing-body types — a state department of public health using a cooperative purchasing vehicle and a county health procurement — but neither procurement actually involves flucloxacillin sodium or antibiotic products in the class this code describes. The Illinois contract, awarded August 28, 2026 for $2,999,999.11 over twelve months plus two renewal options, supplied infectious-disease medications to a state healthcare system. The Seminole County solicitation, posted June 30, 2026 with a due date of July 26, 2023 (date discrepancy in source), sought opioid-reversal and drug-disposal systems through an IFB process. Unless business development efforts target state and local antibiotic supply chains specifically, this code does not reflect active procurement demand in the recent record.